Abstract
The search for an ideal hypolipidemic agent still is underway. A relatively large number of the newer hypolipemic agents are related to ethyl p-chlorophenoxyisobutyrate—among them are compounds with the trivial names or designations of SU 13,437; Sah 42-348; halofenate, treloxinate, S-8527, and two valeric acid derivatives. Other lipopenic agents, whose modes of action are described, are linoleic acid amides, Colestipol, antidiabetic agents, bis (hydroxyethylthio) 1,10-decane, pyridinol carbamate, and some nicotinic acid derivatives.
Similar content being viewed by others
References
Avoy, D.R., E.A. Swyryd, and R.G. Gould, J. Lipid Res. 6:369 (1965).
Azarnoff, D.L., D.R. Tucker, and G.A. Barr, Metabolism 14:959 (1965).
Nestel, P.J., E.Z. Hirsch, and E.A. Couzens, J. Clin. Invest. 44:891 (1965).
Grundy, S.M., E.H. Ahrens, Jr., G. Salen, P.H. Schreibman, and P.J. Nestel, J. Lipid Res. 13:531 (1972).
Duncan, C.H., M.M. Best, and R.J. Lubbe, Metabolism 13:1 (1964).
Failey, R.B., Jr., E. Brown, and M.E. Hodes, Amer. J. Clin. Nutr. 11:4 (1962).
Kritchevsky, D., Fed. Proc. 30:835 (1971).
Hess, R., and W.L. Bencze, Experientia 24:418 (1968).
Kritchevsky, D., and S.A. Tepper, Ibid. 25:699 (1969).
Hartmann, G., and G. Forster, J. Atheroscler. Res. 10:235 (1969).
Oriente, P., M. Motolese, R. Cerqua, and M. Mancini, Int. Z. Klin. Pharmakol. Therap. Toxikol. 2:348 (1969).
Weiss, P., C.A. Dujovne, S. Margolis, L. Lasagna, and J.L. Bianchine, Clin. Pharmacol. Ther. 11:90 (1970).
Timms, A.R., L.A. Kelly, R.S. Ho, and J.H. Trapold, Biochem. Pharmacol. 18:1861 (1969).
Kritchevsky, D., and S.A. Tepper, Arzneimittelforsch 6:858 (1973).
Berkowitz, D., Circulation 40 suppl. 3:44 (1969).
Gilfillan, J.L., V.M. Hunt, and J.W. Huff, Proc. Soc. Exp. Biol. Med. 136:1274 (1971).
Kritchevsky, D., and S.A. Tepper, Ibid. 139:1284 (1972).
Kritchevsky, D., S.A. Tepper, P. Sallata, J.R. Kabakjian, and V.J. Cristofalo, Ibid. 132:76 (1969).
Whitehouse, M.W., E. Staple, and S. Gurin, J. Biol. Chem. 234:276 (1959).
Kariya, T., T.R. Blohm, J.M. Grisar, R.A. Parker, and J.R. Martin, Adv. Exp. Med. Biol. 26:302 (1972).
Grisar, J.M., R.A. Parker, T. Kariya, T.R. Blohm, R.W. Fleming, V. Petrow, D.L. Wenstrup, and R.G. Johnson, J. Med. Chem. 15:1273 (1972).
Toki, K., Y. Nakamura, K. Agatsuma, H. Nakatani, and S. Aono, Atherosclerosis 18:101 (1973).
Kritchevsky, D., and S.A. Tepper, Ibid. 18:93 (1973).
Story, J.A., S.A. Tepper, and D. Kritchevsky, Fed. Proc. 32:690 (abs.) (1973).
Toki, K., and H. Nakatani, Adv. Exp. Med. Biol. 4:491 (1969).
Kritchevsky, D., and S.A. Tepper, J. Atheroscler. Res. 7:527 (1967).
Fukushima, H., S. Aono, Y. Nakamura, M. Endo, and T. Imai, Ibid. 10:403 (1969).
Nakatani, H., H. Fukushima, A. Wakimura, and M. Endo, Science 153:1267 (1966).
Parkinson, T.M., K. Gunderson, and N.A. Nelson, Atherosclerosis 11:531 (1970).
Kritchevsky, D., H.K. Kim, and S.A. Tepper, Proc. Soc. Exp. Biol. Med. 142:185 (1973).
Agid, A., and G. Marquie, “La Via Metabolica Dell’ Aterogenesi,” Edited by G. Labo, Casa Editrice R. Patron, Bologna, Italy, 1972, p. 579.
Czyzyk, A., A. Ostaszynski, H. Plenkiewicz, Z. Szczepanik, and T. Urbanski, Arzneimittelforsch 22:465 (1972).
Assous, E., M. Pouget, J. Nadaud, G. Tartary, M. Henry, and J. Duteil, Therapie 27:395 (1972).
Debray, C., C. Vaille, C. Roze, and M. Souchard, Ibid. 27:423 (1972).
Rouffy, J., and J. Loeper, Ibid. 27:433 (1972).
Altschul, R., A. Hoffer, and J.D. Stephen, Arch. Biochem. Biophys. 54:558 (1955).
Carlson, L.A., C. Hedbom, E. Helgstrand, B. Sjöberg, and N.E. Stjernström, Adv. Exp. Med. Biol. 4:85 (1969).
Carlson, L.A., C. Hedbom, E. Helgstrand, A. Misiorny, B. Sjöberg, N.E. Stjernström, and G. Westin, Acta Pharm. Suecica 9:221 (1972).
Carlson, L.A., C. Hedbom, E. Helgstrand, B. Sjöberg, and N.E. Stjernström, Ibid. 9:289 (1972).
Carlson, L.A., C. Hedbom, E. Helgstrand, A. Misiorny, B. Sjöberg, N.E. Stjernström, and G. Westin, Ibid. 9:411 (1972).
Bailey, D.M., D. Wood, R.E. Johnson, J.P. McAuliff, J.C. Bradford, and A. Arnold, J. Med. Chem. 15:344 (1972).
Shimamoto, T., F. Numano, T. Fujita, T. Ishioka, and T. Atsumi, Asian Med. J. 8:825 (1965).
Shimamoto, T., F. Numano, and T. Fujita, Amer. Heart J. 71:216 (1966).
Shimamoto, T., T. Atsumi, F. Numano, and T. Fujita, Prog. Biochem. Pharmacol. 4:597 (1968).
Kritchevsky, D., and S.A. Tepper, Experientia 23:1006 (1967).
Kritchevsky, D., and S.A. Tepper, Arzneimittelforsch 21:146 (1971).
Kritchevsky, D., J.T. Kolimaga, H.K. Kim, and S.A. Tepper, in “Atherogenesis II,” Edited by T. Shimamoto, C.N. Addison, and F. Numano, Excerpta Medical Foundation, Amsterdam, Holland, 1973, p. 129.
Wu, C.C., T.S. Huang, and C.J. Hsu, Amer. Heart J. 77:657 (1969).
Sanwald, R., and H. Wagener, Adv. Exp. Med. Biol. 26:318 (1972).
Möttönen, M., M. Pantio, and L. Nieminen, Atherosclerosis 15:77 (1972).
Malinow, M.R., A. Perley, and P. McLaughlin, J. Atheroscler. Res. 8:455 (1968).
Malinow, M.R., P. McLaughlin, and A. Perley, Atherosclerosis 15:31 (1972).
Author information
Authors and Affiliations
Additional information
One of six papers presented in the symposium, “Effect of Drugs on Lipid Metabolism,” AOCS Spring Meeting, New Orleans, April 1973.
About this article
Cite this article
Kritchevsky, D. New drugs affecting lipid metabolism. Lipids 9, 97–102 (1974). https://doi.org/10.1007/BF02532133
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02532133